The price of Rani Therapeutics Holdings Inc (NASDAQ:RANI) shares last traded on Wall Street fell -33.33% to $2.12.
RANI stock price is now -16.39% away from the 50-day moving average and -43.35% away from the 200-day moving average. The market capitalization of the company currently stands at $62.09M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $17, Oppenheimer recently initiated with Outperform rating for Rani Therapeutics Holdings Inc (NASDAQ: RANI). On June 14, 2024, Maxim Group recently initiated its ‘Buy’ rating on the stock quoting a target price of $15, while ‘Rodman & Renshaw’ rates the stock as ‘Buy’
In other news, Quiroga Cortes Isidoro Alfonso, 10% Owner sold 5,265,165 shares of the company’s stock on Nov 24 ’23. The stock was sold for $10,582,982 at an average price of $2.01. Upon completion of the transaction, the 10% Owner now directly owns 8,400 shares in the company, valued at $17808.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 24 ’23, 10% Owner South Cone Investments Limited bought 5,265,165 shares of the business’s stock. A total of $10,582,982 was incurred on buying the stock at an average price of $2.01. This leaves the insider owning 12,131,554 shares of the company worth $25.72 million. A total of 48.82% of the company’s stock is owned by insiders.
During the past 12 months, Rani Therapeutics Holdings Inc has had a low of $1.82 and a high of $8.75. As of last week, the company has a debt-to-equity ratio of 12.46, a current ratio of 1.93, and a quick ratio of 1.93. The fifty day moving average price for RANI is $2.53572 and a two-hundred day moving average price translates $3.742305 for the stock.
The latest earnings results from Rani Therapeutics Holdings Inc (NASDAQ: RANI) was released for 2024-06-30. The company reported revenue of $12.52 million for the quarter, compared to $18.29 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -31.54 percent.
